Rockville , Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global high content screening market is estimated at US$1,979.9 million in 2024. The market is projected to grow significantly, with a 6.1% CAGR through 2034. The market is projected to surpass US$ 3,570.0 million by 2034.
The high content screening industry is likely to rise in the coming years, owing to the rising need for personalized medicine, drug research and development, and drug toxicity studies, among other factors.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9417
High content screening and drug toxicity studies are increasingly used in drug research and development. This is because it allows researchers to analyze several biological factors simultaneously, such as cell shape, gene expression, and protein localization, which can aid in identifying prospective drug targets and lead compounds. The growing usage of automated high content screening methods has fueled market expansion by allowing for faster, more accurate, and high-throughput examination of massive cell populations.
The market is growing due to significant research and development activities in drug discovery and innovation. Technological improvements and the availability of high-throughput screening methods facilitate the creation of new medications and cures, promoting the growth of the high content screening market.
| Report Attribute | Details |
| Value Projection (2034) | US$ 3,570 Million |
| Growth Rate (2024-2034) | 6.1% CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 32 Tables |
| No. of Figures | 160 Figures |
Key Takeaways from the Market Study
- The global high content screening market is projected to expand at a CAGR of 6.1% from 2024 to 2034.
- The North America high content screening market is expected to evolve at a CAGR of 5.9% from 2024 to 2034.
- The market is expected to register a CAGR of 6.0% in the United States over the forecast period.
- The high content screening market industry in China is expected to rise at a CAGR of 7.4% through 2034.
- Based on the product type, the cell imaging & analysis segment leads the market, with an expected market share of 4.6% in 2024.
“The growing use of automated methods for high content screening is projected to drive market expansion in the coming years. These automated devices provide excellent precision, accuracy, and speed, allowing researchers to screen many samples quickly and thus present opportunities for market players." says a Fact.MR analyst.
Key Companies Profiled in This Report
- Thermo Fisher Scientific Inc.,
- Becton Dickinson and Company,
- Danaher Corporation,
- Yokogawa Electric Corporation,
- BioTek Instruments Inc.
In 2024, the cell imaging & analysis segment is anticipated to contribute 35.8% to the market share by product type. The forecast period indicates a Compound Annual Growth Rate (CAGR) of 4.6% for cell imaging & analysis.
High Content Screening (HCS) is increasingly gaining popularity in cell imaging and analysis due to its ability to provide a more comprehensive view of cellular processes and responses compared to traditional imaging techniques. HCS allows researchers to analyze multiple parameters simultaneously, facilitating the identification of complex cellular interactions and responses that would be challenging to detect using conventional methods. This technique finds widespread use in drug discovery and development, enabling researchers to screen large libraries of compounds for their effects on specific cellular processes.
Key Segments of High Content Screening Market Research Report
| By Product Type | By Industry Type | By Application | By Region |
|
|
|
|
Competitive Landscape
Companies leverage their strengths and capabilities, offering customers a diverse range of options in the high content screening market. The entry of numerous smaller companies and startups with innovative approaches further adds to the market's dynamism. While competition in this sector is intense, it ensures that customers have access to cutting-edge technologies.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9417
Recent Developments
In 2022, Olympus introduced the SciLog SciPure FD System, an advanced cell imaging system designed for rapid capture of high-quality multicolor images with improved quantitative results.
In the same year, Particle Works, an innovative organization specializing in revolutionary particle engineering solutions, officially launched the Automated Library Synthesis (ALiS) System. This platform prioritizes swift screening of lipid nanoparticle (LNP) formulations and mRNA candidates, introducing automation in the early stages of drug development.
Checkout More Related Studies Published by Fact.MR Research:
Peripheral IV Catheter Market: The global peripheral IV catheter market size is estimated to be US$ 1,058.6 million in 2024. The market is projected to register a CAGR of 5.8% and reach US$ 1,865.4 million by 2034.
Neurology Contract Research Organization Market: The global neurology contract research organization market is expected to be worth US$ 5,923.9 million in 2024. The market is anticipated to expand at a CAGR of 6.8% from 2024 to 2034. The market is predicted to surpass US$ 11,405.8 million in 2034.
OTC Pediatric Healthcare Market: The global OTC pediatric healthcare market is valued at US$ 11 billion in 2023 and is predicted to reach US$ 18 billion by 2033-end. Fact.MR has forecasted the market to expand at a CAGR of 5% from 2023 to 2033.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
